Drug Database
Back to search

Switzerland· 44486002

Ebrantil 50 mg, Injektionslösung

A urapidil product, registered in Switzerland by Cheplapharm Schweiz GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 10 of our 19 countries.

Cat B (Swissmedic)ATC C02CA06

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedEbrantil 50 mg, InjektionslösungATCC02CA06REGISTER NO.44486002PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about EbrantilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Urapidil is registered in 10 of 19 countries.

Countries holding a registration under ATC C02CA06 (urapidil), each read from that country’s own register.

  • This record: Switzerland
  • 6 of them publish a price we can compare per daily dose
Search urapidil products by name

Urapidil · ATC C02CA06

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Cheplapharm Schweiz GmbH
Country
Switzerland (CH)
ATC code
C02CA06
ATC class
Urapidil
Defined daily dose
0.12 g, O
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C02CA06

Urapidil, as other registers publish it.

All urapidil products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7058eda2-83b5-4059-8508-39b2fea83933
GET /v1/drugs/7058eda2-83b5-4059-8508-39b2fea83933?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about urapidil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console